Use access key #2 to skip to page content.
$3.46 -0.19 (-5.21%)
5/16/2008 3:41 PM

XTENT, Inc. (XTNT)

CAPS Rating:
*

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View All Commentary (XTNT)

Recs

0

Avatar TakeAction (< 20) Submitted: 11/08/07 6:14 PM : Outperform Start Price: $10.36 XTNT Score: -64.52

Medical device are about building either a new or better "mouse trap". XTNT has developed a better one than the current stents on the market.





But, they can't go it alone. Too small to effectively compete with the big boys. So guess what? As data looks more promising and patent protection of intellectual capital, they'll get bought. At current market cap of just under $250 million, this should be at a good premium to this level.

Report this Post Replies: 0 | Reply

Featured Broker Partners